Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 12:38:55 15/10/2026 pm IST			5-day change	1st Jan Change
2,489.60 ^INR	-1.96%		-1.78%	+0.75%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	4,30,190	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	11.21%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	4,30,190	4,30,190
Change	-	-18.99%	58.51%	48.08%	-20.64%	11.21%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	36.9x	32.1x
PBR	10.6x	12.9x	18.5x	25x	17.1x	16.2x	13.6x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3x	2.1x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.1x	9.11x
EV / Revenue	0x	0x	0x	0x	0x	10.1x	9.11x
EV / EBITDA	0x	0x	0x	0x	0x	29x	25.2x
EV / EBIT	0x	0x	0x	0x	0x	29.3x	25.1x
EV / FCF	0x	0x	0x	0x	0x	35.8x	32.6x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.79%	3.06%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.16%	1.16%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,539.40	2,539.40
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	36.92x	-	-	1.16%	452.05Cr
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,07700Cr
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	61TCr
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	50TCr
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	36TCr
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	35TCr
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	28TCr
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	25TCr
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	23TCr
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	19TCr
Average	30.28x	6.82x	18.14x	2.08%	38.61TCr
Weighted average by Cap.	35.12x	7.99x	19.65x	1.87%